The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1, first-in-human study of ARQ 087, an oral pan-Fibroblast Growth Factor Receptor (FGFR) inhibitor, in patients (pts) with advanced solid tumors.
 
Kyriakos P. Papadopoulos
Research Funding - Abbvie (Inst); ArQule (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); MedImmune (Inst); Novartis (Inst); Onyx (Inst); Regeneron (Inst); Sanofi (Inst)
 
Anthony W. Tolcher
Stock and Other Ownership Interests - Symphony Evolution
Consulting or Advisory Role - AbbVie; Adnexus; Ambit BioSciences; AP Pharma; Aragon Pharmaceuticals; ARIAD; ArQule; Asana Biosciences; Astellas Pharma; Astex Pharmaceuticals; AVID Radiopharmaceuticals; Bayer Schering Pharma; Bind Therapeutics; BioMed Valley Discoveries; Blend Therapeutics; Bristol-Myers Squibb; Celator; Clovis Oncology; Curis; Dicerna; Eisai; Emergent BioSolutions; Heron; Janssen; Johnson & Johnson; Lilly; MedImmune; Merck Sharp & Dohme; Merus; Micromet; Nanobiotix; Nektar; Neumedicines; Novartis (I); Oncogenex; Pfizer; Pharmacyclics; Pierre Fabre; ProNAi; Proximagen; Symphony Evolution; Vaccinex; Valent Technologies; Zyngenia; Zyngenia
 
Amita Patnaik
Research Funding - ArQule (Inst)
 
Drew Warren Rasco
Research Funding - ArQule (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Five Prime Therapeutics (Inst); Millennium (Inst); Rexahn Pharmaceuticals (Inst); Santa Maria Biotherapeutics (Inst); Teva (Inst)
 
Glenda Chambers
No Relationships to Disclose
 
Murali Beeram
Research Funding - ArQule (Inst)
 
Ronald Savage
Employment - ArQule
Stock and Other Ownership Interests - ArQule
 
Terence Hall
Employment - ArQule
Stock and Other Ownership Interests - ArQule
 
Brian E. Schwartz
Employment - ArQule
Leadership - ArQule
Stock and Other Ownership Interests - ArQule
 
Julia Kazakin
Employment - ArQule
Stock and Other Ownership Interests - ArQule
 
Patricia LoRusso
Consulting or Advisory Role - Astellas Pharma; Astex Pharmaceuticals; Genentech; Novartis
Speakers' Bureau - Genentech
Research Funding - Genentech (Inst); Immunogen (Inst); Merrimack (Inst); Novartis (Inst); Taiho Pharmaceutical (Inst); Tensha Therapeutics (Inst)